Journal
Frontiers in Cardiovascular Medicine
Publication Date
1-1-2022
Volume
9
First Page
907597
Document Type
Open Access Publication
DOI
10.3389/fcvm.2022.907597
Rights and Permissions
Ramsell S, Arias Bermudez C, Takem Baiyee CAM, Rodgers B, Parikh S, Almaani S, Sharma N, LoRusso S, Freimer M, Redder E, Bumma N, Vallkati A, Efebera Y, Kahwash R and Campbell CM (2022) Beta-Adrenergic Antagonist Tolerance in Amyloid Cardiomyopathy. Front. Cardiovasc. Med. 9:907597. doi: 10.3389/fcvm.2022.907597 © 2022 Ramsell, Arias Bermudez, Takem Baiyee, Rodgers, Parikh, Almaani, Sharma, LoRusso, Freimer, Redder, Bumma, Vallkati, Efebera, Kahwash and Campbell. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Recommended Citation
Ramsell, Stuart; Arias Bermudez, Carlos; Takem Baiyee, Cyril Ayuk Mbeng; Rodgers, Brandon; Parikh, Samir; Almaani, Salem; Sharma, Nidhi; LoRusso, Samantha; Freimer, Miriam; Redder, Elyse; Bumma, Naresh; Vallkati, Ajay; Efebera, Yvonne; Kahwash, Rami; and Campbell, Courtney M, "Beta-adrenergic antagonist tolerance in amyloid cardiomyopathy." Frontiers in Cardiovascular Medicine. 9, 907597 (2022).
https://digitalcommons.wustl.edu/oa_4/98
